BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to prescription drug pricing and value Issues related to ICD-10 diagnosis codes Prescription drug manufacturing and supply chains Issues related to 340B program Issues related to tax Issues related to Intellectual Property Issues related to Inflation Reduction Act The Access to Prescription Digital Therapeutic Act of 2023 (S. 723/H.R. 1458)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D redesign Rebate reform Medicaid Drug Rebate Program (MDRP), including value-based purchasing (VBP) arrangements and line extensions Issues related to Biosimilars Issues regarding implementation of the Inflation Reduction Act Issues related to the Treat and Reduce Obesity Act The Access to Prescription Digital Therapeutic Act of 2023 (S. 723/H.R. 1458)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Animals ANI
Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| BILL DAVIS | — |
| MARY BRIDGET WALSH | — |
Trade (domestic/foreign) TRD
Prescription drug manufacturing and supply chains
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHARINE TROLLER BOND | — |
| BILL DAVIS | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Budget/Appropriations BUD
Issues related to FY2024 Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| KATHARINE TROLLER BOND | — |
| BILL DAVIS | — |
| JULIAN MALASI | — |
| SARAH ELIZABETH NORDSTROM | — |
| MARY BRIDGET WALSH | — |
Defense DEF
Issues related to National Defense Authorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT BENNETT | — |
| BILL DAVIS | — |
| MARY BRIDGET WALSH | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM AUSLANDSBETEILIGUNGS GMBH | Germany | Germany | 100.0% | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| BOEHRINGER INGELHEIM ANIMAL HEALTH USA, INC. | Duluth, GA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.